mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.2 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.2 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.3 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.3 |